http://www.has-sante.fr/portail/jcms/c_2598650/fr/tasmar http://www.has-sante.fr/portail/jcms/c_400726/fr/tasmar-100-mg-comprime-pellicule-flacon-s-en-verre-de-100-comprime-s-code-cip-345-466-4 2016 true France French insurance, health, reimbursement evaluation of the transparency committee Catechol O-Methyltransferase Inhibitors drug therapy, combination parkinson disease administration, oral treatment outcome tolcapone Tolcapone antiparkinson agents benzophenones nitrophenols
--- https://www.anses.fr/fr/system/files/SUBCHIM2009SA0331-108.pdf 2015 false false false France French technical report inlets research report albumin/globulin ratio report Exhibition 4-nitrophenol relative nitrophenol nitrophenols effects of exposure to external cause, nos bays
--- https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=116871&nom=Nitro-2+phénol Canada toxicological data sheet nitrophenols
--- https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=157446&nom=Nitro-3+phénol Canada toxicological data sheet nitrophenols
--- https://www.ema.europa.eu/medicines/human/EPAR/Tasmar 2012 false United Kingdom French English syndication feed Catechol O-Methyltransferase Inhibitors Catechol O-Methyltransferase Inhibitors drug evaluation drug therapy, combination parkinson disease tablets administration, oral treatment outcome drug interactions pregnancy breast feeding drug evaluation, preclinical drug labeling drug approval tolcapone drug evaluation summary of product characteristics package leaflet Tolcapone antiparkinson agents antiparkinson agents benzophenones benzophenones nitrophenols benzophenones nitrophenols